3.07
price up icon2.33%   0.07
after-market 시간 외 거래: 3.09 0.02 +0.65%
loading
전일 마감가:
$3.00
열려 있는:
$2.99
하루 거래량:
594.59K
Relative Volume:
0.72
시가총액:
$424.53M
수익:
-
순이익/손실:
$-45.44M
주가수익비율:
-8.7714
EPS:
-0.35
순현금흐름:
$-42.28M
1주 성능:
+5.14%
1개월 성능:
+27.92%
6개월 성능:
+17.62%
1년 성능:
+227.71%
1일 변동 폭
Value
$2.99
$3.135
1주일 범위
Value
$2.855
$3.27
52주 변동 폭
Value
$0.8741
$4.08

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
명칭
Compass Therapeutics Inc
Name
전화
617-500-8099
Name
주소
80 GUEST STREET, BOSTON
Name
직원
35
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CMPX's Discussions on Twitter

CMPX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CMPX
Compass Therapeutics Inc
3.07 403.78M 0 -45.44M -42.28M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-01 재개 Raymond James Outperform
2025-04-02 업그레이드 Leerink Partners Market Perform → Outperform
2025-02-24 개시 Guggenheim Buy
2025-02-19 개시 Piper Sandler Overweight
2024-12-23 개시 D. Boral Capital Buy
2024-11-15 다운그레이드 Leerink Partners Outperform → Market Perform
2024-09-16 업그레이드 Ladenburg Thalmann Neutral → Buy
2023-01-31 개시 Jefferies Buy
2023-01-27 개시 Stifel Buy
2022-05-23 재개 H.C. Wainwright Buy
2022-03-15 개시 Ladenburg Thalmann Buy
2022-01-19 개시 B. Riley Securities Buy
2021-12-22 개시 Raymond James Outperform
2021-12-20 개시 SVB Leerink Outperform
2021-12-15 개시 Wedbush Outperform
모두보기

Compass Therapeutics Inc 주식(CMPX)의 최신 뉴스

pulisher
04:12 AM

What drives Compass Therapeutics Inc. stock priceExceptional portfolio growth - jammulinksnews.com

04:12 AM
pulisher
Jul 20, 2025

Compass Therapeutics Inc. Stock Analysis and ForecastFree Investment Case Studies - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Compass Therapeutics Inc. stockRapid wealth accumulation - Autocar Professional

Jul 19, 2025
pulisher
Jul 18, 2025

Is Compass Therapeutics Inc. stock a growth or value playHigh Return Setup Scanner - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

Is Compass Therapeutics Inc. a good long term investmentConsistent high-yield stocks - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Compass Therapeutics Inc. stock outlookFree Real-Time Market Predictions - beatles.ru

Jul 18, 2025
pulisher
Jul 16, 2025

What makes Compass Therapeutics Inc. stock price move sharply10x Return With Managed Risk - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Compass Therapeutics Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Axsome Therapeutics Inc. stock performs during market volatilityMulti Bagger Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Compass Therapeutics Inc. stock performs during market volatilityBreakout Level Watch - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Compass Therapeutics And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Stifel reiterates Buy rating on Compass Therapeutics stock with $11 target - Investing.com Canada

Jul 15, 2025
pulisher
Jul 14, 2025

Contrasting Compass Therapeutics (NASDAQ:CMPX) & Generation Bio (NASDAQ:GBIO) - Defense World

Jul 14, 2025
pulisher
Jul 11, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of “Buy” by Brokerages - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

Compass Therapeutics (CMPX) soars 4.01% on FDA Fast Track Designation - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

Vontobel Holding Ltd. Invests $57,000 in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jul 10, 2025
pulisher
Jul 04, 2025

Compass Therapeutics: Promising Clinical Trials and Strategic Confidence Earn Buy Rating - AInvest

Jul 04, 2025
pulisher
Jul 02, 2025

Compass Therapeutics (NASDAQ:CMPX) Upgraded at Raymond James Financial - Defense World

Jul 02, 2025
pulisher
Jul 01, 2025

Compass Therapeutics: Raymond James reinstates Outperform rating, $9 PT. - AInvest

Jul 01, 2025
pulisher
Jun 30, 2025

Compass Therapeutics, Inc.(NasdaqCM: CMPX) added to Russell 3000E Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 26, 2025

Compass Therapeutics Completes Phase 2 Study on CTX-009 for Metastatic Colorectal Cancer - TipRanks

Jun 26, 2025
pulisher
Jun 23, 2025

Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results - Benzinga

Jun 23, 2025
pulisher
Jun 17, 2025

PD-1 and PD-L1 Inhibitors Competitor Landscape Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Compass Therapeutics, Aurigene Discovery Tech - The Globe and Mail

Jun 17, 2025
pulisher
Jun 16, 2025

SG Americas Securities LLC Buys 545,767 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Acquired by Bank of America Corp DE - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 48,021 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Compass Therapeutics Confirms Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Cholangiocarcinoma Market Booming Worldwide, Estimated to Reach USD 2,334.4 Mn by 2032 | Incyte CorporationSOUTHEAST - SOUTHEAST - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 12, 2025

Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist - Yahoo Finance

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Acquires New Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

CMPX to Participate in Virtual Meeting Hosted by Piper Sandler | - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

CMPX to Participate in Virtual Meeting Hosted by Piper Sandler | CMPX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Cuts Stake in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Transition Metals (CVE:XTM) Shares Up 62.5% – Time to Buy? - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Makes New $27,000 Investment in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Has $42,000 Position in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 05, 2025
pulisher
May 29, 2025

Northern Trust Corp Sells 43,164 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 29, 2025
pulisher
May 29, 2025

Compass Therapeutics, Inc. (CMPX) Stock Analysis: A Biotech Gem with Over 500% Potential Upside - DirectorsTalk Interviews

May 29, 2025
pulisher
May 28, 2025

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 27, 2025

Insider Buying: Thomas Schuetz Acquires Additional Shares of Com - GuruFocus

May 27, 2025

Compass Therapeutics Inc (CMPX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):